I think NP has painted himself into a corner. Either he

New Post Public Reply Private Reply Replies (3) Message Board
MarcS RTB #82815
767
I think NP has painted himself into a corner. Either he obtains some kind of immediate approval or he obtains immediate revenue somewhere (you know that is his job), he's out. And, if he is out, the share price will gap up on the open at least $1 to $2 above the prior close upon his resignation or removal. I don't think that is debatable at this point.
He needs to close the deal NOW. No more BS excuses on how long it takes biotechs to get drugs to market. It's like a runner getting to just before the finish line and just stops running while all the other runners pass him by.
Stop the talk of this being a penny stock for ten years or whatever, and how successful we are to be where we are. I did not buy in the pennies, it's a many dollars stock to me. Even, those of you lucky enough to have bought in the pennies deserve better than being reminded of having held a penny stock for the last ten years prior to last year.
The lawsuit that forced him and certain others to return stock and option grants is a prelude of more to come if the board does not take care of this problem. With distribution of the shares of the stock comes the ability of shareholders to vote the board of directors out of office if they don't take care of situations such as this.
It's like he is afraid of changes, the going is good for him and certain others, with their large salaries. Afraid that if they succeed, there will be changes. Well, the changes will come either way, so the executives and board are better to be the cause of the changes, rather than those removed for failing to make those changes.
PS, don't anyone accuse me of being a short, I own tens of thousands of shares, and increased my shares after the famous Local Station 3-figure NP interview article just before the results. Keep in mind that I now, and many others now, believe that if he left, it is a plus for the company. As above stated, if he left, I believe the share price will gap up on the open.
The coach that gets almost to the Title every year, but just can't close the deal. That coach gets replaced by one that can close the deal.
4

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 1

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
UNISORB Expands Reach with BILZ Acquisition

Updated Category News Views 0

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 4

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Backroads Sets 2027 Egypt Tour with Active Adventures

Updated Category News Views 1

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
Evotec and Plectonic Join Forces on Tumor Immunotherapy

Updated Category News Views 4

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading

Top 5 Most Recently Viewed Articles

The Future of Antigen and Antibody Diagnostics: A $68 Billion Vision

Updated Category News Views 125

Antigen and Antibody Diagnostics Market: Overview of Growth Trends The field of antigen and antibody diagnostics is experiencing unprecedented growth, fueled by innovations in technology and an increasing demand for effective disease detection solutions. The market was estimated at around $43 billion recently, and projections indicate it could soar to approximately $68...

Continue Reading
Columbus A/S Updates on Recent Share Buyback Program

Updated Category News Views 124

Columbus A/S: Overview of Current Share Buyback Program Columbus A/S has embarked on an exciting journey to enhance shareholder value through a systematic share buyback program. This initiative aims to repurchase shares for an impressive total of up to DKK 16 million, marking a significant investment in the company's future and commitment to its shareholders. Details of...

Continue Reading
Rithm Capital Corp. Announces Q4 2024 Dividend Declarations

Updated Category News Views 245

Rithm Capital Corp. Announces Fourth Quarter 2024 Dividends Rithm Capital Corp. (NYSE:RITM) has proudly declared both common and preferred stock dividends for the fourth quarter of 2024. The announcement was made by the Company’s Board of Directors, reflecting their continued commitment to return value to shareholders. Details of Common Stock Dividend The Board has...

Continue Reading
Introducing ISU Steadfast: A New Era in Insurance Networks

Updated Category News Views 1109

ISU Steadfast: A Blend of Strength and Experience ISU Insurance Agency Network has initiated a major transformation by rebranding itself as ISU Steadfast. This change signifies a unique moment where ISU's rich history merges with the global insights and expertise of Steadfast Group, enabling both organizations to leverage their strengths collaboratively. The Evolution of...

Continue Reading
Edelson Lechtzin Investigates Quantum Corp for Alleged Misconduct

Updated Category News Views 220

Edelson Lechtzin LLP Takes Action Against Quantum Corporation Edelson Lechtzin LLP has initiated an investigation concerning Quantum Corporation (NASDAQ: QMCO) related to possible breaches of federal securities laws. This investigation arises from concerns over allegations that the company might have shared misleading information regarding its business operations with...

Continue Reading